United Therapeutics CorporationUTHRNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$71.42
Net Income/Share$29.03
Operating CF/Share$35.53
Free CF/Share$25.61
Cash/Share$63.19
Book Value/Share$150.46
Tangible Book/Share$147.80
Equity/Share$150.46
Interest Debt/Share$0.55
CapEx/Share$9.92
Dividend/Share$0.00
Valuation
Market Cap$21.03B
Enterprise Value$19.89B
P/E Ratio16.01P/S Ratio6.72P/OCF Ratio13.09
P/FCF Ratio18.74
P/B Ratio3.09P/TB Ratio3.09
EV/Sales6.36EV/EBITDA11.66
Graham Valuation
Graham Number$313.52
Graham Net-Net$52.93
Profitability
Earnings Yield6.24%FCF Yield5.34%ROE18.83%ROIC16.75%Return on Tangible Assets17.58%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF27.91%
CapEx/Revenue13.88%
CapEx/Depreciation5.26
SBC/Revenue4.34%
SG&A/Revenue14.03%
R&D/Revenue17.40%
Liquidity & Solvency
Debt/Equity0.00Debt/Assets0.00Debt/Market Cap0.00
Net Debt/EBITDA-0.67
Current Ratio6.40Interest Coverage61.46xIncome Quality1.22Efficiency
Days Sales Outstanding35 days
Days Payables Outstanding479 days
Days Inventory181 days
Receivables Turnover10.51x
Payables Turnover0.76x
Inventory Turnover2.02x
Capital Structure
Tangible Assets$6.47B
Working Capital$2.95B
Invested Capital$4.62B
Intangibles/Assets1.59%